Report Highlights
The global DNA data storage market should reach $1.5 billion by 2027 from $105.5 million in 2022 at a compound annual growth rate (CAGR) of 69.8% for the forecast period of 2022 to 2027.
Report Includes
- 57 tables
- An up-to-date overview and analysis of the global markets for DNA data storage technologies
- Analyses of the global market trends, with historic revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the market potential for global DNA data storage technologies market, growth driving factors, and areas of focus to forecast this market into various segments and subsegments
- Estimation of the actual market size and revenue forecast for global DNA data storage market in USD million terms, and corresponding market share analysis by type, component, application, deployment, sequencing platform, end-user industry and region
- Understanding of the DNA data storage technologies; DNA sequencing (read) and synthesis (write) technologies; industry structure; large-scale DNA read, write and storage initiatives and population-scale sequencing projects
- Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and other region-specific macroeconomic factors shaping the market demand for DNA data storage technologies over the coming years (2022-2027)
- Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
- Updated information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the global market
- Company profile descriptions of leading industry players, including 10x Genomics Inc., Agilent Technologies Inc., Illumina Inc., and Twist Bioscience Corp.
Report Scope
The scope of the report includes DNA data storage technologies, applications, industries, initiatives, patents, and companies. The market estimates for DNA data storage products and services are provided for 2020 as the base year, 2021, and forecast through year-end 2027.
This report reviews DNA data storage technologies, including DNA read and write technologies. It then discusses significant large-scale research initiatives that impact DNA storage, read, and write applications. The main market driving forces for DNA data storage products and services are discussed.
The report quantifies each of the main market segments for DNA data storage according to the following segments: by type (commercial, research, and prototyping); by deployment (cloud, on-premise); by application (archival, quality control, research, and prototyping); by end user (banking, financial services, and insurance; government and defense; healthcare and pharma; media and entertainment; and other); by sequencing platform (next generation sequencing, nanopore sequencing); by synthesis platform (chemical-column based; chemical-microchip based; enzymatic); and by geography (Asia-Pacific, Europe, North America, and Rest of the World).
The report also includes profiles of the key companies in the DNA data storage industry. In addition, BCC Research provides a summary of the main industry acquisitions and strategic alliances from January 2019 through December 2022, including key alliance trends.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Forecast period considered | 2022 to 2027 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Base year market size | $64.9 million | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market size forecast | $1.5 billion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Growth rate | CAGR of 69.8% for the forecast period of 2022-2027 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segments covered | application, deployment, synthesis, sequencing technology, end-user, and region | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Countries covered | United States, Mexico, Canada, Austria, Belgium, Czech Republic, Denmark, Estonia, France, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom, Australia, China, India, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Argentina, Brazil, Chile, Israel, Kuwait, Russia, Saudi Arabia, South Africa, United Arab Emirates | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa (HLC305A)
- Global Biochip Markets: Microarrays and Lab-on-a-Chip (BIO049G)
- Contract Manufacturing: Global Markets to 2030 (MFG062B)
- Global Markets for Allergy Diagnostics and Treatments (PHM026D)
- Global Markets for Telemedicine Technologies (HLC014M)
Related Reports
Global Biochip Markets: Microarrays and Lab-on-a-Chip
The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.
Proteomics: Technologies and Global Markets
The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
2024 Cell and Gene: Research Review
Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.
Single-Cell Genomics and Proteomics: Emerging Technologies and Markets
The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Biochip Markets: Microarrays and Lab-on-a-Chip
The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.
Global Cell Line and Membrane Market
The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.
Human Microbiome-based Drugs and Diagnostics: Global Markets
The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.
Global Microbiome Sequencing Market
The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.
Proteomics: Technologies and Global Markets
The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The global market for DNA data storage should grow from $36.4 million in 2020 to $525.3 million by 2025 with a compound annual growth rate (CAGR) of 70.6% for the period of 2020-2025.
Report Inludes
- 40 tables
- An overview of the global markets and technologies for DNA data storage
- Analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Description of DNA data storage technologies; DNA sequencing (read) and synthesis (write) technologies; industry structure; large-scale DNA read, write and storage initiatives and population-scale sequencing projects
- Details about components, deployment technologies and applications of DNA data storage
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size, and market forecast of the DNA data storage markets
- A look at the key industry acquisitions, strategic alliances and market share analysis of the leading suppliers of the industry
- Comprehensive profiles of major players in the industry, including Agilent Technologies Inc., Sigma Aldrich Corp., Generay Biotech Co. Ltd., Omega Bio-Tek Inc., Illumina Inc. and Thermo Fisher Scientific Inc.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More